Ghorbani, Samira
Jelinek, Emily
Jain, Rajiv
Buehner, Benjamin http://orcid.org/0000-0003-2241-0062
Li, Cenxiao
Lozinski, Brian M. http://orcid.org/0000-0003-0940-0169
Sarkar, Susobhan
Kaushik, Deepak K.
Dong, Yifei http://orcid.org/0000-0003-1483-2046
Wight, Thomas N.
Karimi-Abdolrezaee, Soheila http://orcid.org/0000-0002-0683-2663
Schenk, Geert J.
Strijbis, Eva M. http://orcid.org/0000-0001-6705-5864
Geurts, Jeroen
Zhang, Ping
Ling, Chang-Chun
Yong, V. Wee http://orcid.org/0000-0002-2600-3563
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (1049959)
Article History
Received: 13 June 2021
Accepted: 13 April 2022
First Online: 4 May 2022
Competing interests
: PZ, CCL and VWY have a patent application (USA Patent application number 17/059,318) pending on the use of difluorosamine in multiple sclerosis. Other authors declare no competing interests.